Proactive Investors - Run By Investors For Investors

eWellness Healthcare to launch a digital occupational therapy platform by the end of 2019

CEO Darwin Fogt says the platform will cater to strong interest from third-party insurers in a digital occupational therapy platform
eWellness PHIZIO platform
eWellness Healthcare’s proprietary PHZIO platform is robust enough to handle 30 different patients online at a time

eWellness Healthcare Corporation (OTCMKTS:EWLL) announced Monday that it will develop and launch a digital occupational therapy platform by the end of this year.

“Based upon interest by various third-party insurance administrators, we are excited to create a digital occupational therapy platform similar to our PHZIO PT treatment platform,” said eWellness Healthcare CEO Darwin Fogt in a statement.

According to IBIS World, the US occupational therapy market was valued at approximately $24.3 billion in 2017.

READ: Florida passes telehealth law, opening door to out-of-state providers like eWellness Healthcare

“When coupled with the PT and speech therapy markets, this will provide eWellness Healthcare with three distinct silos of ancillary health care services with a combined market size of approximately $90 billion per year in the US,” said Fogt.

As a physical therapy telehealth company, eWellness Healthcare offers insurance-reimbursable, real-time, distance-monitored treatments. The company’s PHZIO platform lowers treatment costs, expands treatment access and improves patient compliance.

The company's goal is to transform the way the estimated $35 billion market for physical therapy works in the US by licensing its PHZIO platform to physical therapist clinics.

The Culver City, California-based company has operations in the US and Canada.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

View full EWLL profile View Profile

eWellness Healthcare Corp. Timeline

Related Articles

cancer scan
January 03 2019
The company, which owns a piece of software which predicts the effects of drugs on cancers, has recently extended a lucrative agreement with German firm Merck Serono while it has also signed a strategic collaboration with the Medicines Discovery Catapult
test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
An illustration of Ozop's BLIF technique
March 30 2019
A key area of focus for the West Palm Beach, Florida, company is development of balloon lumbar interbody fusion (BLIF) technology
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use